🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yoshiki Kudo

Hiroshima University

ORCID: 0000-0001-6542-3408

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta”.

Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta

Scientific Reports(2022)10.1038/s41598-022-14104-1

N/A

0DataRank · unranked

11 citations

Danny J. Schust, Tomomi Yamazaki, Yoshiki Kudo, Jun Sugimoto

Controlling Trophoblast Cell Fusion in the Human Placenta—Transcriptional Regulation of Suppressyn, an Endogenous Inhibitor of Syncytin-1

Biomolecules(2023)10.3390/biom13111627

N/A

0DataRank · unranked

13 citations

Danny J. Schust, Makiko Sugimoto, Yoshihiro Jinno, Yoshiki Kudo, Jun Sugimoto

Genetic Diversity in the Suppressyn Gene Sequence: From Polymorphisms to Loss-of-Function Mutations

Biomolecules(2025)10.3390/biom15071051

N/A

0DataRank · unranked

2 citations

Danny J. Schust, Takeshi Nagamatsu, Yoshihiro Jinno, Yoshiki Kudo, Jun Sugimoto

Variations in blood levels of the anti-fusogenic endogenous retroviral protein suppressyn are associated with fetal growth outcome in preeclampsia

Scientific Reports(2025)10.1038/s41598-025-22275-w

N/A

0DataRank · unranked

0 citations

Danny J. Schust, Takeshi Nagamatsu, Eriko Yano, Makiko Sugimoto, Tomomi Yamazaki +2 more